MedImprove
ActiveSummary
MedImprove has been active since 2020 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €301,052 and a net result of €176,363. Equity is growing by about 32% per year across the filed financial years. Its solvency ranks better than 30% of 268 sector peers (NACE 72, financial year 2025). The computed 12-month bankruptcy probability is 0.6% (low).
Group and network
Holdings and subsidiaries
1 holdingHoldings 1
- Medimprove IncUSSourceown accounts 202520.86%
According to the 2025 annual accounts of MedImprove and those of the other companies, the acts in the Belgian Official Gazette and the LEI register. Annual accounts state the shareholders that notified the company under article 7:225 of the Code of Companies and Associations and the parent companies that consolidate it. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not include these statements in its annual accounts, or does not have to, is not listed.
Connections & network
No directors read yet: 1 of 7 Gazette acts processed.